Literature DB >> 7615462

On-line measurement of nitric oxide generation in buffer-perfused rabbit lungs.

R Spriestersbach1, F Grimminger, N Weissmann, D Walmrath, W Seeger.   

Abstract

In buffer-perfused rabbit lungs, the mixed expired gas was continuously analyzed for nitric oxide (NO) by chemiluminescence detection, and recovery data in dependency of the alveolar O2 tension were established. A small aliquot of the lung effluent was continuously forwarded to a reaction vessel in which the NO decomposition products nitrite, peroxynitrite, and nitrate [summarized as NOx; acidic vanadium (III) chloride reagent] or nitrite (acidic sodium iodide reagent) were quantitatively reduced back to NO, which was then transferred to a second chemiluminescence detector. Under baseline conditions, the perfused lungs continuously released 2.2 +/- 0.21 nmol/min of NO (n = 10) into the gas space. NO was permanently liberated into the intravascular compartment at 7.0 +/- 0.3 nmol/min (n = 4). According to a very low buffer-gas partition coefficient of NO (estimated to be 0.0292 +/- 0.005 in separate equilibration experiments), NO aerated into the prelung perfusate largely escaped into the alveolar space within one lung passage, whereas only low percentages of inhaled NO were detected as NOx in the buffer medium. Immediate increase of lung NO generation in response to A-23187 challenge and inhibition by NG-monomethyl-L-arginine were demonstrated. In conclusion, in buffer-perfused lungs, total NO generation may be monitored by continuous analysis of NO exhalation and perfusate NOx accumulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615462     DOI: 10.1152/jappl.1995.78.4.1502

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  5 in total

1.  Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy.

Authors:  R Schulz; D Schmidt; A Blum; X Lopes-Ribeiro; C Lücke; K Mayer; H Olschewski; W Seeger; F Grimminger
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

2.  Nebulization of the acidified sodium nitrite formulation attenuates acute hypoxic pulmonary vasoconstriction.

Authors:  Bakytbek Egemnazarov; Ralph T Schermuly; Bhola K Dahal; Garry T Elliott; Niel C Hoglen; Mark W Surber; Norbert Weissmann; Friedrich Grimminger; Werner Seeger; Hossein A Ghofrani
Journal:  Respir Res       Date:  2010-06-21

3.  Effects of hypercapnia and NO synthase inhibition in sustained hypoxic pulmonary vasoconstriction.

Authors:  Farzaneh Ketabchi; Hossein A Ghofrani; Ralph T Schermuly; Werner Seeger; Friedrich Grimminger; Bakytbek Egemnazarov; S Mostafa Shid-Moosavi; Gholam A Dehghani; Norbert Weissmann; Natascha Sommer
Journal:  Respir Res       Date:  2012-01-31

Review 4.  Exercise and NO production: relevance and implications in the cardiopulmonary system.

Authors:  Alexei V Nosarev; Lyudmila V Smagliy; Yana Anfinogenova; Sergey V Popov; Leonid V Kapilevich
Journal:  Front Cell Dev Biol       Date:  2015-01-07

Review 5.  Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.

Authors:  Hossein A Ghofrani; Ian H Osterloh; Friedrich Grimminger
Journal:  Nat Rev Drug Discov       Date:  2006-08       Impact factor: 84.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.